With Naurex, Allergan potentially expands its development of mental health treatments, as the acquired company’s focus is on developing therapies for brain and nervous system disorders like depression.
Janssen Pharmaceuticals announced that the Food and Drug Administration approved the company's supplemental new drug application for the once-monthly Invega Sustenna (paliperidone palmitate), an antipsychotic used to treat schizoaffective disorder as either monotherapy or adjunctive therapy.
Walgreens opened a new training facility here in partnership with Have Dreams, an advocacy group for children with autism, according to a story published Wednesday by Evanston Now.
The training involves setting up displays, working the cash register, stocking and organizing shelves and other skill sets that enable the autistic students to make a contribution to a store’s operations.
In July, the country’s largest trade group representing the drug industry released a report showing nearly 200 drugs under clinical development or Food and Drug Administration review for treating mental disorders.
CVS Caremark announced today its partnership with The Miracle Project, a nonprofit organization that creates social skills programs for children with autism through the performing arts, to expand The Miracle Project School Inclusion Program to public schools in San Diego and San Jose, Calif.
Improving patients’ beliefs about their medication therapies may significantly improve medication adherence, according to a set of studies sponsored by drug maker Merck and presented last month at the International Society for Pharmacoeconomics and Outcomes Research’s 16th annual international meeting in Baltimore.
Such mood disorders as anxiety and depression may be a precursor to diabetes in Latinos, according to a study by University of California at San Diego researchers scheduled for presentation at the American Psychiatric Association’s annual meeting in Honolulu.